General Information of Drug Inactive Ingredient (DIG) (ID: E00564)

DIG Name
Sodium laureth-3 sulfate
Synonyms
SODIUM LAURYL TRIOXYETHYLENE SULFATE; 13150-00-0; Sodium laureth-3 sulfate; Sodium lauryl(triethylene glycol) sulfate; UNII-BPV390UAP0; BPV390UAP0; sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate; Dodecyltriethoxy sulfate; Sodium lauryl triethoxy sulfate; HSDB 5056; Sodium lauryl tri(oxyethyl) sulfate; EINECS 236-091-0; Triethylene glycol dodecyl ether sulfate sodium salt; Sodium lauryl alcohol triglycol ether sulfate; Ethanol, 2-(2-(2-(dodecyloxy)ethoxy)ethoxy)-, 1-(hydrogen sulfate), sodium salt (1:1); Ethanol, 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]-, 1-(hydrogen sulfate), sodium salt (1:1); Sodium lauryltrioxyethylene sulfate; Triethylene glycol monododecyl ether sulfate sodium salt; Sodium 2-(2-(2-(dodecyloxy)ethoxy)ethoxy)ethyl sulphate; 2-(2-(2-(Dodecyloxy)ethoxy)ethoxy)ethanol hydrogen sulfate sodium salt; Ethanesulfonic acid, 2-(2-(2-(dodecyloxy)ethoxy)ethoxy)-, sodium salt; Ethanol, 2-(2-(2-(dodecyloxy)ethoxy)ethoxy)-, hydrogen sulfate, sodium salt; Ethanol, 2-(2-(2-(dodecyloxy)ethoxy)ethoxy)-, sulfate ester, monosodium salt; Sulfuric acid, mono(2-(2-(2-(dodecyloxy)ethoxy)ethoxy)ethyl) ester, sodium salt; SCHEMBL818230; DTXSID3052852; sodium triethylene glycol monolauryl ether sulfate; Q27274802; Sodium 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl sulfate; UNII-19Q4RW8UWP component SXHLENDCVBIJFO-UHFFFAOYSA-M; UNII-5G80BO01PI component SXHLENDCVBIJFO-UHFFFAOYSA-M
DIG Function
Surfactant
Formula
C18H37NaO7S
Canonical SMILES
CCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)[O-].[Na+]
InChI
1S/C18H38O7S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-22-13-14-23-15-16-24-17-18-25-26(19,20)21;/h2-18H2,1H3,(H,19,20,21);/q;+1/p-1
InChIKey
SXHLENDCVBIJFO-UHFFFAOYSA-M
Physicochemical Properties Molecular Weight 420.5 Topological Polar Surface Area 103
XlogP N.A. Complexity 374
Heavy Atom Count 27 Rotatable Bond Count 21
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 7

Full List of Drug(s) Co-administrated with This DIG

2 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Ciclopirox DMN5T2A Cutaneous candidiasis [1F23.14] Ciclopirox 1% shampoo F23681
Fenofibrate DMFKXDY Coronary atherosclerosis [] Fenofibrate 160 mg tablet F08005
------------------